Studies

Find NIHR BioResource approved studies based on area of study, type of study (participant recall, samples and data, data only) and active state.

For detailed information on specific data see https://bioresourcesupport.org.uk/genetic-data-from-snp-chips-arrays/

 

Your search returned 119 studies

Studies 10-18 of 119

Evaluation of the immune response to vaccines in patients previously infected with COVID-19 : COV-VAX-IR

Speciality area
Infection

Study type
Participant re-contact

Research lead
Dr Anita Chandra

COVID-19 Immune Phenotyping Programme (CIPP) and COVID National BioResource.

Speciality area
Infection

Study type
Participant re-contact

Research lead
Professor Ken Smith

Determining and mapping out the medium to long term sequelae of COVID-19 and identify factors that account for different disease outcomes

Speciality area
Infection

Study type
Data only

Research lead
Dr Nyarie Sithole

Neutrophil reprogramming in COVID-19

Speciality area
Infection

Study type
Participant re-contact

Research lead
Dr James Nathan

Complement activation to predict Sars-CoV-2 outcome

Speciality area
Infection

Study type
Samples and data

Research lead
Dr Richard Unwin

Healthcare Worker Case Control COVID-19 Questionnaire

Speciality area
Infection

Study type
Participant re-contact

Research lead
Dan Cooper

Healthcare Worker COVID follow up

Speciality area
Infection

Study type
Participant re-contact

Research lead
Dan Cooper

Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patients

Speciality area
Gastroenterology

Study type
Participant re-contact

Research lead
Professor Graham Lord

HICC: Humoral Immune Correlates for COVID19: Defining protective Ab responses and critical readouts for Clinical Trials of Vaccines and Therapeutics

Speciality area
Infection

Study type
Participant re-contact

Research lead
Dr Helen Baxendale